Skip to content

The effect of the Top&Fit intervention program and the effect of muscle strength on the activities of daily living of aging people at risk for cardiovascular diseases

The effect of the Top&Fit intervention program and the effect of muscle strength on the activities of daily living of aging people at risk for cardiovascular diseases - Effect of the Top&Fit intervention on activities of daily living

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35345
Enrollment
80
Registered
2010-07-30
Start date
2009-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular diseases

Interventions

The intervention contains of two swimming lessons in the week for 42 weeks. Each session consists of one hour physical activity with both technique and endurance type exercise to improve the overall

Sponsors

Sint Annaziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 45 years or older - at risk of cardiovascular diseases - able to perform a capacity test on a cycle ergo meter

Exclusion criteria

Exclusion criteria: - at high risk of cardiovascular diseases - already have a cardiovascular disease - had previous hart failure or stroke - have a pacemaker or comparable apparatus - Subjects may not participate in any form of organised physical - or sports like activity at the start of the study

Design outcomes

Primary

MeasureTime frame
The activities of daily living is the main parameter. The purpose of the intervention is to help people in becoming more active in daily living. Furthermore the muscle strength and respiratory fitness level will increase due to the intervention. Due to the increased physical activity the subjects will have a decrease in cardiovascular risk and other disease risk factors

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)